Ling and colleagues identified transgene overexpression-induced cytotoxicity in their previously reported AAV9- based gene replacement therapy for SURF1- related Leigh syndrome. By optimizing the vector design, they now developed an improved version that showed efficacy equivalent to their original design, but without associated cytotoxicity in wildtype rats.